Home Newsfeeds Piper Sandler Downgrades NGM Biopharmaceuticals to Neutral

Piper Sandler Downgrades NGM Biopharmaceuticals to Neutral

Piper Sandler analyst Swapnil Malekar downgrades NGM Biopharmaceuticals (NASDAQ:NGM) from Overweight to Neutral.

byBenzinga Newsdesk

October 17, 2022

1 minute read

Piper Sandler analyst Swapnil Malekar downgrades NGM Biopharmaceuticals (NASDAQ:NGM) from Overweight to Neutral.

Analyst Says Bitcoin Is More Likely To Surge Than Plummet

By Bibhu Pattnaik

May 13, 9:44 AM

Well-known cryptocurrency analyst Tone Vays says that the chances of Bitcoin (CRYPTO: BTC) surging by over 30% from the current levels are higher than the probability of the

BTC

Deutsche Bank Maintains Hold on Morgan Stanley, Lowers Price Target to $92

By Benzinga Newsdesk

September 12, 9:28 AM

Deutsche Bank analyst Matt O'Connor maintains Morgan Stanley (NYSE:MS) with a Hold and lowers the price target from $105 to $92.

News

Conifer Announces Strategic Partnership With Palomar Serving The Cannabis Industry

By Benzinga Newsdesk

April 1, 10:03 AM

Conifer Holdings, Inc. (NASDAQ:CNFR) ("Conifer") today announced that it recently launched a strategic partnership with Palomar Holdings, Inc. ("Palomar") aimed at providing comprehensive coverage tailored specifically

CNFR

Supermicro Provides Q2 Fiscal 2024 Business Update; Updates Q2 EPS Guidance From $4.40-$4.88 To $5.40-$5.55 Vs $4.52 Est.; Net Sales From $2.7B-$2.9B To $3.6B-$3.65B Vs $2.78B Est.

By Benzinga Newsdesk

January 19, 9:37 AM

Supermicro, (NASDAQ:SMCI), a Total IT Solution Manufacturer for AI, Cloud, Storage and 5G/Edge, today announced preliminary financial results for the second quarter of fiscal year 2024, ended December 31, 2023.With a

SMCI

Piper Sandler Downgrades NGM Biopharmaceuticals to Neutral

Related Posts

Analyst Says Bitcoin Is More Likely To Surge Than Plummet

Deutsche Bank Maintains Hold on Morgan Stanley, Lowers Price Target to $92

Conifer Announces Strategic Partnership With Palomar Serving The Cannabis Industry

Supermicro Provides Q2 Fiscal 2024 Business Update; Updates Q2 EPS Guidance From $4.40-$4.88 To $5.40-$5.55 Vs $4.52 Est.; Net Sales From $2.7B-$2.9B To $3.6B-$3.65B Vs $2.78B Est.